Complications of corticosteroid therapy in patients with the acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia
- PMID: 2361410
- DOI: 10.1378/chest.98.1.38
Complications of corticosteroid therapy in patients with the acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia
Abstract
We retrospectively studied the acute toxicity of corticosteroid therapy in 23 episodes of PCP occurring in the setting of AIDS and determined the incidence of HIV-related complications following these and 16 other contemporaneous episodes of AIDS-related PCP treated with antimicrobials alone. The mean duration of corticosteroid therapy was 5.4 days and the mean total dose was 660 mg of methylprednisolone. Cryptococcus neoformans and Listeria monocytogenes infection each occurred once within one month of therapy in corticosteroid-treated patients; no other noteworthy acute corticosteroid toxicity was noted. Since all patients with imminently lethal PCP received corticosteroids, we could not assess the effect of these agents on acute mortality. After six months the rates of new AIDS-related diagnoses and of post-hospitalization mortality were equivalent in the two groups. We also have critically reviewed the available literature regarding this use of corticosteroids.
Similar articles
-
Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy.Mayo Clin Proc. 1996 Jan;71(1):5-13. doi: 10.4065/71.1.5. Mayo Clin Proc. 1996. PMID: 8538233
-
A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. California Collaborative Treatment Group.N Engl J Med. 1990 Nov 22;323(21):1451-7. doi: 10.1056/NEJM199011223232104. N Engl J Med. 1990. PMID: 2233917 Clinical Trial.
-
Markedly reduced mortality associated with corticosteroid therapy of Pneumocystis carinii pneumonia in children with acquired immunodeficiency syndrome.Arch Pediatr Adolesc Med. 1994 Jun;148(6):638-41. doi: 10.1001/archpedi.1994.02170060092018. Arch Pediatr Adolesc Med. 1994. PMID: 8193693
-
Adjuvant corticosteroid therapy for Pneumocystis carinii pneumonia in AIDS patients.Ann Pharmacother. 1992 Sep;26(9):1127-33. doi: 10.1177/106002809202600915. Ann Pharmacother. 1992. PMID: 1421680 Review.
-
High-dose corticosteroid therapy for Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome.South Med J. 1989 Jun;82(6):711-4, 718. doi: 10.1097/00007611-198906000-00009. South Med J. 1989. PMID: 2660289 Review.
Cited by
-
Neuromuscular complications of human immunodeficiency virus infection and antiretroviral therapy.West J Med. 1994 May;160(5):447-52. West J Med. 1994. PMID: 8048229 Free PMC article. Review.
-
Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection: a meta-analysis of randomised controlled trials.BMC Infect Dis. 2005 Nov 7;5:101. doi: 10.1186/1471-2334-5-101. BMC Infect Dis. 2005. PMID: 16271157 Free PMC article.
-
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans.Clin Microbiol Rev. 1995 Oct;8(4):515-48. doi: 10.1128/CMR.8.4.515. Clin Microbiol Rev. 1995. PMID: 8665468 Free PMC article. Review.
-
Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection.Cochrane Database Syst Rev. 2015 Apr 2;2015(4):CD006150. doi: 10.1002/14651858.CD006150.pub2. Cochrane Database Syst Rev. 2015. PMID: 25835432 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical